Shazmah Shaikh/LinkedIn
Mar 30, 2026, 17:29
Shazmah Shaikh: Stroke Care Is Not Just Treatment – It’s Timing, Precision, and Strategy
Shazmah Shaikh, Doctor of Pharmacy at BLDE Association’s College of Pharmacy, shared on LinkedIn:
”In stroke management, timing isn’t important… it’s EVERYTHING.
Within the first few hours, the goal is clear:
Save brain tissue. Restore blood flow. Act FAST.
- Thrombolytics like Alteplase
- Mechanical thrombectomy
These interventions can reverse damage if done on time.
But here’s what many don’t realize
After 24 hours, aggressive interventions may do more harm than good
The focus shifts to:
- Preventing further damage
- Stabilizing the patient
- Long-term recovery and rehabilitation
Stroke care is not just treatment — it’s timing, precision, and strategy
Every minute delay equals loss of millions of neurons
As healthcare professionals, understanding this timeline can literally save lives
For educational purposes only.
Consult a healthcare professional.”

Stay updated with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 23:13Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight